Future Procurement Opportunity (FPO) - Supply of COVID-19 vaccines Details RFx ID: 29557585
Tender Name: Future Procurement Opportunity (FPO) - Supply of COVID-19 vaccines
51000000 - Drugs and Pharmaceutical Products
Regions:
New Zealand
Required Pre-qualifications: None
Contact: Pharmac Procurement Team
******
Pharmac is planning to issue a competitive process for supply of COVID-19 vaccines. Pharmac would be interested in considering offers for vaccines that use alternative technologies to those used in currently funded COVID-19 vaccines.
To enable Pharmac to consider listing a new vaccine through the RFP, we would need a recommendation, either from PTAC or the Immunisation Advisory Committee, that the vaccine is suitable for use in New Zealand. The suggested approach would be for suppliers to submit funding applications for potential new vaccines that have not already been considered by the Immunisation Advisory Committee, as soon as possible.
Pharmac is looking to change the way COVID-19 vaccines are funded and distributed to align more closely with other vaccines and pharmaceuticals. We want to enable more equitable health outcomes in a way that is mutually sustainable for both the New Zealand health system and suppliers. We are interested in hearing from suppliers early to help inform the development of this procurement.
The indicative release date that the buying agency expects a realized procurement process to commence; the FPO will close on this date. Please note that the date will be presented to suppliers by calendar quarter.
Initial Development (Concept Phase) - the buying agency is investigating options to procure in the future (high-level information expected around the activity). Budget may or may not be available.
The indicative combined value of any realized tenders that may arise from this FPO is intended to set an expectation of the scope of work that is required.
An individual agency purchasing on its own behalf.
#J-18808-Ljbffr